Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402Gregory Cairncross, Walter J. Curran, Minesh P. Mehta et al.|Journal of Clinical Oncology|2006Cited by 725
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersRicardo V. Lloyd, Bernd W. Scheithauer|American Journal Of Pathology|1999Cited by 592
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, Sunil Krishnan et al.|Journal of Clinical Oncology|2008Cited by 275
Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H. Uhm, Kurt A. Jaeckle, Karla V. Ballman et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 186
Gonadotropic pituitary carcinoma: HER-2/neu expression and gene amplificationFederico Roncaroli, Jonathan A. Fletcher, Vânia Nosé et al.|Journal of neurosurgery|2003Cited by 43